ZURA: Zura Bio Ltd Sotuvga nisbatan narx
Antitelolarning klinik sinovlari agressiv kengayganiga qaramay, GURU.Markets daromad koeffitsiyentining chiziqli grafigini taqdim etadi, bunda joriy daraja ni tashkil etadi. Ushbu narx harakati FDA ning qat'iy tartibga soluvchi to'siqlari va patentlarni ishlab chiqish murakkabligi bilan zidlik tashkil etadi. Zura Bio Limited ichki muvaffaqiyati rahbarlikning ilmiy intizomi va inqilobiy tibbiy natijalarga erishish uchun kapitalning samarali taqsimlanishi bilan ta'minlanmoqda.
Zura Bio Limited (ZURA) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati zurabio.com|ZURA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Zura Bio Limited|ZURA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Zura Bio|Oraliq qoplama koeffitsiyenti zurabio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
ZURA - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Zura Bio Limited|ZURA - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Zura Bio Ltd|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Zura Bio Limited|ZURA - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Zura Bio|ZURA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi zurabio.com|ZURA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Zura Bio Limited
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Zura Bio Ltd, ZURA
Professional kapital Zura Bio Limited (ZURA) kompaniyasini uning antitelalari yallig'lanish patologiyalarini davolashdagi salohiyati prizmasidan baholaydi va bozor qiymatini joriy daromadlar bilan solishtiradi. Sotuvlar nisbatini (price-to-sales multiple) tahlil qilish orqali investor daromadning har bir dollari narxini aniqlaydi, bu esa aktivlarning haddan tashqari qimmat baholanganini o'z vaqtida tan olish va klinik portfelga nisbatan ortiqcha kutuvlar fonida kuchli pasayish bilan bog'liq xavflarni yumshatish imkonini beradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA: Kapitalizatsiyaning daromadga nisbati|Narxning sotuvga nisbati PTGX|IMVT (Immunovant, Inc.) - Kapitalizatsiyaning daromadga nisbati|kiniksa.com (KNSA) - P/S multiplikatori|Narxning daromadga nisbati Grifols|ADPT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CLDX|P/S multiplikatori Aurinia Corp (AUPH)|BioCryst - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Therapeutics, Inc. - P/S multiplikatori|PHVS: Narxning daromadga nisbati|ABCL: P/S multiplikatori|TRML - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Precigen, Inc.|Sotuvga nisbatan narx pharming.com PHAR|Kapitalizatsiyaning daromadga nisbati NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Immunome Bio - Narxning daromadga nisbati|Gossamer Bio, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti kalvista.com KALV|Septerna (SEPN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|SVRA (Savara Corp) - P/S multiplikatori|Rigel Corp (RIGL) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati ANAB (AnaptysBio, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati ATXS|P/S multiplikatori ENGN (enGene)|RAPT Therapeutics Inc. (RAPT) - Sotuvga nisbatan narx|Aerovate - P/S multiplikatori|ACRS (Aclaris Therapeutics, Inc) - Kapitalizatsiya va daromad nisbati|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|Narxning sotuvga nisbati TLSA (tizianalifesciences.com)|Kapitalizatsiyaning daromadga nisbati CABA|P/S multiplikatori Ventyx Biosciences Inc.|Narxning daromadga nisbati Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELDN (Eledon Pharmaceuticals)|P/S multiplikatori agenusbio.com AGEN|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG: P/S multiplikatori|Ikena Oncology - Bozor kapitallashuvining daromadga nisbati|STTK (Shattuck Labs Inc) - P/S multiplikatori|P/S multiplikatori Equillium Bio|Narxning daromadga nisbati Connect Biopharma (CNTB)|IMUX (immunic-therapeutics.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Atara Bio ATRA|IFRX - Kapitalizatsiyaning daromadga nisbati|X4 Pharmaceuticals - P/S multiplikatori|ACET - P/S multiplikatori|CELU (celularity.com) - Kapitalizatsiyaning daromadga nisbati|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|BRNS (Barinthus Bio) - P/S multiplikatori|Kezar Life Sciences Inc (KZR) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|Kapitalizatsiyaning daromadga nisbati akaritx.com AKTX|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalizatsiyaning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|EDSA - P/S multiplikatori|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CARM|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Sotuvga nisbatan narx Bolt Bio BOLT|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|APVO: Narxning sotuvga nisbati|AIM ImmunoTech Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Aditxt Inc. ADTX|GRI - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati XRTX (XORTX Therapeutics Inc)|HIND: P/S multiplikatori|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati INDP|SCNI: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CALI|Narxning daromadga nisbati AFMD (affimed.com)|P/S multiplikatori ALLK (Allakos)|Narx/daromad koeffitsiyenti HOOKIPA Pharma, Inc. (HOOK)|IGMS - Narxning daromadga nisbati|Sotuvga nisbatan narx iteostherapeutics.com|OCEA (Ocean Biomedical) - Kapitalizatsiyaning daromadga nisbati|TC BioPharm (Holdings) Plc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Third Harmonic Bio, Inc
